Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Union
MedTech
EU orders Illumina to split from Grail as penance for $8B deal
The European Commission ordered Illumina to cut ties with the cancer test maker Grail, more than a year after vetoing its acquisition.
Conor Hale
Oct 12, 2023 11:14am
Edwards Lifesciences named the subject of EU antitrust probe
Sep 26, 2023 11:37am
Illumina sets deadline for proxy fight over board seats
Apr 21, 2023 10:35am
EU commission adopts proposal to delay MDR implementation
Jan 6, 2023 11:03am
Devicemakers cutting products amid new EU regulations: Reuters
Dec 19, 2022 10:45am
Almirall signs on with clinical trial project to collect data
Nov 29, 2022 10:32am